PortfoliosLab logoPortfoliosLab logo
CRBU vs. QS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CRBU vs. QS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Caribou Biosciences, Inc. (CRBU) and QuantumScape Corporation (QS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CRBU achieves a 25.79% return, which is significantly higher than QS's -15.93% return.


CRBU

1D
-13.79%
1M
4.71%
YTD
25.79%
6M
7.53%
1Y
90.48%
3Y*
-25.26%
5Y*
10Y*

QS

1D
-4.78%
1M
21.84%
YTD
-15.93%
6M
-29.41%
1Y
114.18%
3Y*
9.57%
5Y*
-21.06%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

CRBU vs. QS - Yearly Performance Comparison


2026 (YTD)20252024202320222021
CRBU
Caribou Biosciences, Inc.
25.79%0.00%-72.25%-8.76%-58.38%-7.54%
QS
QuantumScape Corporation
-15.93%100.77%-25.32%22.57%-74.45%-1.11%

Correlation

The correlation between CRBU and QS is 0.36, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.36

Correlation (3Y)
Calculated over the trailing 3-year period

0.40

Correlation (All Time)
Calculated using the full available price history since Jul 26, 2021

0.44

Fundamentals

Market Cap

CRBU:

$191.72M

QS:

$5.35B

EPS

CRBU:

-$1.41

QS:

-$0.72

PB Ratio

CRBU:

1.88

QS:

4.82

Total Revenue (TTM)

CRBU:

$8.81M

QS:

$0.00

Gross Profit (TTM)

CRBU:

$7.49M

QS:

-$49.03M

EBITDA (TTM)

CRBU:

-$115.23M

QS:

-$378.92M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CRBU vs. QS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRBU
CRBU Risk / Return Rank: 7171
Overall Rank
CRBU Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
CRBU Sortino Ratio Rank: 7373
Sortino Ratio Rank
CRBU Omega Ratio Rank: 6868
Omega Ratio Rank
CRBU Calmar Ratio Rank: 7272
Calmar Ratio Rank
CRBU Martin Ratio Rank: 6767
Martin Ratio Rank

QS
QS Risk / Return Rank: 7272
Overall Rank
QS Sharpe Ratio Rank: 7474
Sharpe Ratio Rank
QS Sortino Ratio Rank: 7878
Sortino Ratio Rank
QS Omega Ratio Rank: 7474
Omega Ratio Rank
QS Calmar Ratio Rank: 7171
Calmar Ratio Rank
QS Martin Ratio Rank: 6464
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CRBU vs. QS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Caribou Biosciences, Inc. (CRBU) and QuantumScape Corporation (QS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CRBUQSDifference

Sharpe ratio

Return per unit of total volatility

1.09

1.12

-0.03

Sortino ratio

Return per unit of downside risk

1.92

2.22

-0.30

Omega ratio

Gain probability vs. loss probability

1.22

1.26

-0.04

Calmar ratio

Return relative to maximum drawdown

1.78

1.70

+0.08

Martin ratio

Return relative to average drawdown

3.15

2.69

+0.45

CRBU vs. QS - Sharpe Ratio Comparison

The current CRBU Sharpe Ratio is 1.09, which is comparable to the QS Sharpe Ratio of 1.12. The chart below compares the historical Sharpe Ratios of CRBU and QS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CRBUQSDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.09

1.12

-0.03

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.25

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.41

-0.02

-0.39

Drawdowns

CRBU vs. QS - Drawdown Comparison

The maximum CRBU drawdown since its inception was -97.58%, roughly equal to the maximum QS drawdown of -97.36%. Use the drawdown chart below to compare losses from any high point for CRBU and QS.


Loading charts...

Drawdown Indicators


CRBUQSDifference

Max Drawdown

Largest peak-to-trough decline

-97.58%

-97.36%

-0.22%

Max Drawdown (1Y)

Largest decline over 1 year

-51.06%

-67.68%

+16.62%

Max Drawdown (3Y)

Largest decline over 3 years

-91.12%

-73.93%

-17.19%

Max Drawdown (5Y)

Largest decline over 5 years

-91.45%

Current Drawdown

Current decline from peak

-93.40%

-93.35%

-0.05%

Average Drawdown

Average peak-to-trough decline

-79.27%

-85.54%

+6.27%

Ulcer Index

Depth and duration of drawdowns from previous peaks

28.84%

42.53%

-13.69%

Volatility

CRBU vs. QS - Volatility Comparison

The current volatility for Caribou Biosciences, Inc. (CRBU) is 21.48%, while QuantumScape Corporation (QS) has a volatility of 22.76%. This indicates that CRBU experiences smaller price fluctuations and is considered to be less risky than QS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CRBUQSDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.48%

22.76%

-1.28%

Volatility (6M)

Calculated over the trailing 6-month period

49.24%

45.95%

+3.29%

Volatility (1Y)

Calculated over the trailing 1-year period

83.67%

102.34%

-18.67%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

86.84%

85.62%

+1.22%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

86.84%

105.90%

-19.06%

Dividends

CRBU vs. QS - Dividend Comparison

Neither CRBU nor QS has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

CRBU vs. QS - Financials Comparison

This section allows you to compare key financial metrics between Caribou Biosciences, Inc. and QuantumScape Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00M2022202320242025202600
(CRBU) Total Revenue
(QS) Total Revenue
Values in USD except per share items

Frequently Asked Questions


CRBU and QS have a correlation of 0.36, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

QS has higher volatility (22.76%) compared to CRBU (21.48%). In terms of maximum drawdown, CRBU dropped -97.58% vs QS's -97.36%.

QS currently has the higher Sharpe Ratio (1.12 vs 1.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CRBU and QS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer